Advertisement
U.S. Markets closed

Zydus Lifesciences Limited (ZYDUSLIFE.BO)

BSE - BSE Real Time Price. Currency in INR
988.20-17.00 (-1.69%)
At close: 03:29PM IST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
3/31/2024
3/31/2023
3/31/2022
3/31/2021
3/31/2020
Total Revenue
200,152,000
190,215,000
168,778,000
148,276,000
141,250,000
-
Cost of Revenue
64,121,000
65,004,000
65,589,000
58,189,000
50,708,000
-
Gross Profit
136,031,000
125,211,000
103,189,000
90,087,000
90,542,000
-
Operating Expense
85,223,000
79,816,000
74,640,000
65,320,000
63,168,000
-
Operating Income
50,808,000
45,395,000
28,549,000
24,767,000
27,374,000
-
Net Non Operating Interest Income Expense
635,000
776,000
-541,000
-511,000
-1,146,000
-
Pretax Income
53,794,000
48,089,000
25,897,000
28,381,000
23,992,000
-
Tax Provision
11,975,000
9,775,000
5,878,000
5,117,000
1,936,000
-
Net Income Common Stockholders
41,925,000
38,595,000
19,603,000
44,873,000
21,336,000
-
Diluted NI Available to Com Stockholders
41,925,000
38,595,000
19,603,000
44,873,000
21,336,000
-
Basic EPS
27.74
38.14
19.30
43.83
20.84
-
Diluted EPS
27.74
38.14
19.30
43.83
20.84
-
Basic Average Shares
1,012,012
1,011,927
1,015,650
1,023,743
1,023,743
-
Diluted Average Shares
1,012,012
1,011,927
1,015,650
1,023,743
1,023,743
-
Rent Expense Supplemental
-
261,000
229,000
206,000
215,000
-
Total Expenses
149,344,000
144,820,000
140,229,000
123,509,000
113,876,000
-
Net Income from Continuing & Discontinued Operation
41,925,000
38,595,000
19,603,000
44,873,000
21,336,000
-
Normalized Income
40,752,130
37,522,059
29,455,893
20,281,493
24,011,814
-
Interest Income
-
1,268,000
757,000
688,000
495,000
-
Interest Expense
581,000
440,000
1,255,000
1,144,000
1,559,000
-
Net Interest Income
635,000
776,000
-541,000
-511,000
-1,146,000
-
EBIT
54,375,000
48,529,000
27,152,000
29,525,000
25,551,000
-
EBITDA
62,371,000
56,170,000
34,379,000
36,886,000
32,799,000
-
Reconciled Cost of Revenue
64,121,000
65,004,000
65,589,000
58,189,000
50,708,000
-
Reconciled Depreciation
7,996,000
7,641,000
7,227,000
7,361,000
7,248,000
-
Net Income from Continuing Operation Net Minority Interest
41,685,000
38,365,000
19,649,000
22,416,000
22,016,000
-
Total Unusual Items Excluding Goodwill
1,200,000
1,058,000
-5,001,000
2,604,000
-2,171,000
-
Total Unusual Items
1,200,000
1,058,000
940,000
2,604,000
-2,171,000
-
Normalized EBITDA
61,171,000
55,112,000
33,439,000
34,282,000
34,970,000
-
Tax Rate for Calcs
0
0
0
0
0
-
Tax Effect of Unusual Items
267,130
215,059
-1,135,107
469,493
-175,186
-